Translational Research in Oncology (TRIO) Named Top Alberta Employer for Second Year

EDMONTON, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) — Translational Research in Oncology (TRIO), a global academic clinical research organization, is pleased to be recognized as one of Alberta’s Top 70 Employers, an editorial competition that recognizes Alberta’s best places to work.

“Well-being has taken on new meaning this year,” says Kristina Leung, Senior Editor of the Canada’s Top 100 Employers project. “With the uncertainty of the past year, organizations have had to go the extra distance to ensure that folks are cared for and have the necessary supports for their physical, emotional, and financial wellbeing.”

“We are proud to be named one of Alberta’s Top Employers for the second year in a row,” stated Dr. Launa Aspeslet, TRIO’s Chief Executive Officer. “This past year has seen an unprecedented need for employers to get it right. Our commitment to provide a positive and engaging employee experience has never been stronger. When our employees succeed, TRIO succeeds.”


About Alberta’s Top Employers


First published in 2006, Alberta’s Top Employers is a special designation that recognizes Alberta employers that lead their industries in offering exceptional places to work. Employers throughout Alberta were evaluated by the editors at Canada’s Top 100 Employers using the same criteria as the national competition: (1) Physical Workplace; (2) Work Atmosphere & Social; (3) Health, Financial & Family Benefits; (4) Vacation & Time Off; (5) Employee Communications; (6) Performance Management; (7) Training & Skills Development; and (8) Community Involvement. Employers are compared to other organizations in their field to determine which offer the most progressive and forward-thinking programs. The annual competition is open to any employer with its head office in Alberta, and employers of any size may apply, whether private or public sector.


About TRIO


TRIO advances translational cancer research by introducing innovative and novel targeted therapeutic concepts into the clinical trial setting. With international offices in Edmonton (Canada), Paris (France), Montevideo (Uruguay), TRIO’s global reach is expansive. Our goal as a not-for-profit clinical research organization is to find the shortest path to saving lives. Additional information on TRIO can be found by visiting https://www.trioncology.org.

Interested parties may also follow TRIO on Twitter (twitter.com/TRIOncology) or LinkedIn at TRIO – Translational Research in Oncology.


TRIO Media Inquiries:


Launa Aspeslet, PhD
CEO, TRIO
Email: [email protected]
Phone: 780-702-2260



NCSBN joins COVID-19 Vaccine Education and Equity Project

Chicago, Jan. 26, 2021 (GLOBE NEWSWIRE) — NCSBN has joined the COVID-19 Vaccine Education and Equity Project in working to provide information about the clinical trials process, regulatory review, and distribution of and access to potential COVID-19 vaccines in a way that promotes equity and trust.

This partnership is one component in NCSBN’s ongoing effort to provide recommendations about vaccine administration, offer free COVID-19 continuing education courses for health care providers and lead in advocating for a practice/academic partnerships that enable nursing students to gain access to vital clinical experiences. As NCSBN pursues these endeavors, it maintains its paramount goal of ensuring that its NCLEX examinations remain operational and available to candidates in order to funnel new nurses into the workforce.

 

“The COVID-19 pandemic is one of the greatest challenges that the global health care community has ever faced. NCSBN recognizes that the equitable distribution and administration of vaccines is the only way to end this crisis,” notes NCSBN CEO David C. Benton, RGN, PhD, FFNF, FRCN, FAAN. “NCSBN is proud to serve as a leader in educating the public about vaccine safety and building confidence in the process.”

 

NCSBN joins more than 75 other organizations in supporting the overall mission of the COVID-19 Vaccine Education and Equity Project, and participating in and amplifying activities and project-approved materials that promote open dialogue, engagement and effective communication around approved COVID-19 vaccines in the U.S.

 

About NCSBN

 

Founded March 15, 1978, as an independent not-for-profit organization, NCSBN was initially created to lessen the burdens of state governments and bring together nursing regulatory bodies (NRBs) to act and counsel together on matters of common interest. It has evolved into one of the leading voices of regulation across the world.

 

NCSBN’s membership is comprised of the NRBs in the 50 states, the District of Columbia, and four U.S. territories — American Samoa, Guam, Northern Mariana Islands and the Virgin Islands. There are three exam user members. There are also 27 associate members that are either NRBs or empowered regulatory authorities from other countries or territories.

 

Mission: NCSBN empowers and supports nursing regulators in their mandate to protect the public.

 

The statements and opinions expressed are those of NCSBN and not individual members.

######



Dawn M. Kappel
NCSBN
3122182418
[email protected]

Canadian Pacific Railway Limited declares dividend

PR Newswire

CALGARY, AB, Jan. 26, 2021 /PRNewswire/ – The Board of Directors of Canadian Pacific Railway Limited (TSX: CP) (NYSE: CP) today declared a quarterly dividend of $0.95 per share on the outstanding Common Shares.

The dividend is payable on April 26, 2021 to holders of record at the close of business on March 26, 2021, and is an “eligible” dividend for purposes of the Income Tax Act (Canada) and any similar provincial/territorial legislation.

About Canadian Pacific

Canadian Pacific is a transcontinental railway in Canada and the United States with direct links to major ports on the west and east coasts. CP provides North American customers a competitive rail service with access to key markets in every corner of the globe. CP is growing with its customers, offering a suite of freight transportation services, logistics solutions and supply chain expertise. Visit cpr.ca to see the rail advantages of CP. CP-IR

Cision View original content:http://www.prnewswire.com/news-releases/canadian-pacific-railway-limited-declares-dividend-301215525.html

SOURCE Canadian Pacific

NOTICE SPLK DEADLINE Zhang Investor Law Reminds Investors with Losses of the Deadline in Securities Class Action Lawsuit Against Splunk Inc. – SPLK

NEW YORK, Jan. 26, 2021 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Splunk Inc. (NASDAQ: SPLK) between October 21, 2020 and December 2, 2020, inclusive (the “Class Period”).

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=splunk-inc&id=2509 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=splunk-inc&id=2509

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; Splunk was not hitting the financial targets it had previously announced; and as a result of the foregoing, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than February 2, 2021.

Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
[email protected]
tel: (800) 991-3756



Sycamore Partners Reaches Agreement to Recapitalize and Retain Control of Belk

Belk Stores and Business Operations Continue as Normal; Suppliers Unimpaired and Paid in the Ordinary Course

Proposed Financial Restructuring Includes Reduction of Approximately $450 Million in Debt and Commitments for $225 Million of New Capital

PR Newswire

CHARLOTTE, N.C., Jan. 26, 2021 /PRNewswire/ — Belk today announced that it has entered into a Restructuring Support Agreement (the “RSA”) with its majority owner, Sycamore Partners, a private equity firm specializing in consumer, retail and distribution investments, and holders of over 75% of its first lien term loan debt and holders of 100% of its second lien term loan debt on a plan to recapitalize the business, significantly reduce debt by approximately $450 million, and extend maturities on all term loans to July 2025. Under the terms of the RSA, Sycamore Partners will retain majority control of Belk. The retailer has received financing commitments for $225 million in new capital from Sycamore Partners, leading global investment firms KKR and Blackstone Credit, and certain existing first lien term lenders (the “Ad Hoc First Lien Lender Group”). Pursuant to the RSA, members of an ad hoc crossover lender group led by KKR Credit and Blackstone Credit (the “Ad Hoc Crossover Lender Group”) and other participating lenders will acquire a minority ownership in Belk.

Under the RSA, suppliers will be unimpaired and will continue to be paid in the ordinary course for all goods and services provided to the company. Belk plans to continue normal operations throughout its financial restructuring process. Customers will continue to receive the quality merchandise and service they expect when shopping at Belk’s stores across the Southeast and online. The infusion of new capital is expected to support Belk’s continued investment in strategic initiatives, including delivering a seamless omnichannel shopping experience and expanding Belk’s product offerings in Home Goods, Outdoor and Wellness.

“Belk has a 130-year legacy of providing quality products at great prices,” said Lisa Harper, Belk CEO. “Like all retailers navigating COVID-19, our priority has been the safety of our associates, customers and communities. As the ongoing effects of the pandemic have continued, we’ve been assessing potential options to protect our future. We’re confident that this agreement puts us on the right long-term path toward significantly reducing our debt and providing us with greater financial flexibility to meet our obligations and to continue investing in our business, including further enhancements and additions to Belk’s omnichannel capabilities.”

Belk expects to complete the financial restructuring transaction through an expedited “pre-packaged” reorganization under Chapter 11 of the U.S. Bankruptcy Code. The company expects the transaction to be completed by the end of February.                      

Kirkland & Ellis LLP is serving as legal adviser, Lazard is serving as financial adviser, and Alvarez & Marsal North America, LLC is serving as restructuring adviser to Belk. Latham & Watkins LLP is serving as legal advisor to Sycamore Partners. Willkie Farr & Gallagher LLP is serving as legal advisor and PJT Partners LP is serving as financial advisor to the Ad Hoc Crossover Lender Group and O’Melveny & Myers LLP is serving as legal advisor and Evercore is serving as financial advisor to the Ad Hoc First Lien Lender Group. 

About Belk

Charlotte-based Belk, Inc., a privately-owned department store, opened its first store in 1888, beginning a legacy of selling great products at great prices, treating customers like family and giving back to the community. Today, Belk serves customers at nearly 300 Belk stores in 16 Southeastern states, at belk.com and through the mobile app. For over 130 years, Belk has proudly put customers and community at the center of what they do, supporting local charities, organizations and families when they need it most.

For more information visit https://newsroom.belk.com/.

To shop, find your local store at https://www.belk.com/stores/, visit belk.com or download the Belk app in Google Play or Apple Store.

About Sycamore Partners

Sycamore Partners is a private equity firm based in New York. The firm specializes in consumer, distribution and retail-related investments and partners with management teams to improve the operating profitability and strategic value of their business. With approximately $10 billion in aggregate committed capital raised since its inception in 2011, Sycamore Partners’ investors include leading endowments, financial institutions, family offices, pension plans and sovereign wealth funds. For more information on Sycamore Partners, visit www.sycamorepartners.com.

About KKR

KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, credit and real assets, with strategic partners that manage hedge funds. KKR aims to generate attractive investment returns for its fund investors by following a patient and disciplined investment approach, employing world-class people, and driving growth and value creation with KKR portfolio companies. KKR invests its own capital alongside the capital it manages for fund investors and provides financing solutions and investment opportunities through its capital markets business. References to KKR’s investments may include the activities of its sponsored funds. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co.

Contacts

Belk

Jennifer Anderson

Senior Director, Communications
[email protected]

Sycamore Partners

Michael Freitag or Arielle Rothstein
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449

KKR

Cara Major or Miles Radcliffe-Trenner
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/sycamore-partners-reaches-agreement-to-recapitalize-and-retain-control-of-belk-301215521.html

SOURCE Belk

QSR DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Restaurant Brands International Inc. – QSR

NEW YORK, Jan. 26, 2021 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Restaurant Brands International Inc. (NYSE: QSR) between April 29, 2019 and October 28, 2019, inclusive (the “Class Period”).

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=restaurant-brands-international-inc&id=2541 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=restaurant-brands-international-inc&id=2541

If you wish to serve as lead plaintiff, you must move the Court before the February 19, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. 

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that- Restaurant Brands’ “Winning Together Plan” was failing to generate substantial, sustainable improvement within the Tim Hortons brand; the “Tims Rewards” loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and as a result, defendants’ statements about Restaurant Brands’ business, operations, and prospects lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
[email protected]
tel: (800) 991-3756



Truist Declares Common and Preferred Stock Dividends

PR Newswire

CHARLOTTE, N.C., Jan. 26, 2021 /PRNewswire/ — The Board of Directors of Truist Financial Corporation (NYSE: TFC) declared a regular quarterly cash dividend of $0.45 per common share, payable on March 1, 2021, to shareholders of record at the close of business on February 12, 2021.

The Board also declared regular cash dividends on the following series of preferred stock:


Series of Preferred Stock


Dividend per Share 


Dividend per Depositary Share 


Record


Date


Payment


Date

Series F Non-Cumulative Perpetual Preferred Stock (CUSIP 89832Q851)

$325.00

$0.325

February 12

March 1

Series G Non-Cumulative Perpetual Preferred Stock (CUSIP 89832Q844)

$325.00

$0.325

February 12

March 1

Series H Non-Cumulative Perpetual Preferred Stock (CUSIP 89832Q836)

$351.5625

$0.3515625

February 12

March 1

Series I Non-Cumulative Perpetual Preferred Stock (CUSIP 89832Q810)

$1,000.00

$0.25

February 12

March 15

Series J Non-Cumulative Perpetual Preferred Stock (CUSIP 86800XAA6)

$1,000.00

$10.00

February 12(1)

March 15

Series N Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock

(CUSIP 89832QAD1)

$600.00

$24.00

February 12

March 1(2)

Series O Non-Cumulative Perpetual Preferred Stock (CUSIP 89832Q745)

$328.125

$0.328125

February 12

March 1

Series Q Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock

(CUSIP 89832QAF6)

$892.50

$35.70

February 12

March 1(2)

Series R Non-Cumulative Perpetual Preferred Stock (CUSIP 89832Q695)

$296.875

$0.296875

February 12

March 1

Notes:

(1)  In accordance with the Amended and Restated Declaration of Trust of SunTrust Preferred Capital I, the record date for the Preferred Purchase Securities representing fractional interests in shares of Series J preferred stock will be February 28, 2021.

(2)  Dividends per share and dividends per depositary share for Series N and Series Q are declared and paid semiannually.


About Truist

Truist Financial Corporation is a purpose-driven financial services company committed to inspire and build better lives and communities. With the combined history of BB&T and SunTrust, Truist has leading market share in many high-growth markets in the country. The company offers a wide range of services including retail, small business and commercial banking; asset management; capital markets; commercial real estate; corporate and institutional banking; insurance; mortgage; payments; specialized lending; and wealth management. Headquartered in Charlotte, North Carolina, Truist is the sixth-largest commercial bank in the U.S. with total assets of $509 billion as of December 31, 2020. Truist Bank, Member FDIC. Learn more at Truist.com.

Cision View original content:http://www.prnewswire.com/news-releases/truist-declares-common-and-preferred-stock-dividends-301215518.html

SOURCE Truist Financial Corporation

NOTICE FEB 2 DEADLINE: Zhang Investor Law Reminds Investors with Losses of the Deadline in Securities Class Action Lawsuit Against  Northern Dynasty Minerals Ltd. – NAK

NEW YORK, Jan. 26, 2021 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of   Northern Dynasty Minerals Ltd. (NYSE: NAK)  between December 21, 2017 and November 25, 2020, inclusive (the “Class Period”).

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=northern-dynasty-minerals-ltd&id=2517 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=northern-dynasty-minerals-ltd&id=2517

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: the Company’s Pebble Project was contrary to Clean Water Act guidelines and to the public interest; the Company planned that the Pebble Project would be larger in duration and scope than conveyed to the public; as a result, the Company’s permit applications for the Pebble Project would be denied by the U.S. Army Corps of Engineers; and as a result, Defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than February 2, 2021.

Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
[email protected]
tel: (800) 991-3756



DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Triterras, Inc. f/k/a Netfin Acquisition Corp. – TRIT, TRITW

NEW YORK, Jan. 26, 2021 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Triterras, Inc. f/k/a Netfin Acquisition Corp. (NASDAQ: TRIT, TRITW) between August 20, 2020 and December 16, 2020, inclusive (the “Class Period”).

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=triterras-inc&id=2539 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=triterras-inc&id=2539

If you wish to serve as lead plaintiff, you must move the Court before the February 19, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. 

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that- the extent to which the Company’s revenue growth relied on Triterras’ relationship with Rhodium Resources Pte. Ltd. (“Rhodium”) to refer users to the Kratos platform; that Rhodium faced significant financial liabilities that jeopardized its ability to continue as a going concern; that, as a result, Rhodium was likely to refer fewer users to the Company’s Kratos platform; and that, as a result of the foregoing, defendants’ positive statements about Triterras’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
[email protected]
tel: (800) 991-3756



DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against GoodRx Holdings, Inc. – GDRX

NEW YORK, Jan. 26, 2021 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the “Class Period”).

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=goodrx-holdings-inc&id=2531 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=goodrx-holdings-inc&id=2531

If you wish to serve as lead plaintiff, you must move the Court before the February 16, 2021 DEADLINE.   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. 

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that-   Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx.  Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO.  According to the GoodRx class action lawsuit, given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, their statements in the Registration Statement and during the Class Period about GoodRx’s competitive position were materially false and/or misleading when made and caused GoodRx Class A common stock to trade at artificially inflated prices of more than $64 per share during the Class Period.

Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
[email protected]
tel: (800) 991-3756